Related Experiment Video
Updated: Mar 25, 2026
12:18
Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
23.8K
Adverse Drug Reactions in Hospitalized Pediatric Patients: A Prospective Observational Study
J Kurian1, J Mathew1, K Sowjanya1
1Department of Pharmacy Practice, JSS College of Pharmacy, JSS University, Mysore, Karnataka, 570015, India.
Indian Journal of Pediatrics
|February 27, 2016
Summary
Adverse drug reactions (ADRs) occurred in 4.99% of pediatric patients, with infants, males, and those on multiple medications being most at risk. Continuous monitoring is crucial for pediatric drug safety.
Area of Science:
- Pediatric Pharmacology
- Drug Safety and Pharmacovigilance
- Clinical Pharmacy
Background:
- Adverse drug reactions (ADRs) pose a significant risk in pediatric populations.
- Understanding the incidence, causality, and predictors of ADRs is crucial for improving patient safety.
Purpose of the Study:
- To determine the incidence, pattern, causality, preventability, severity, and predictors of adverse drug reactions (ADRs) in pediatric patients.
- To identify risk factors associated with ADRs in children.
Main Methods:
- A prospective, observational study was conducted in a tertiary care hospital's pediatric wards.
- Data on ADRs were collected and analyzed for incidence, causality (WHO Probability scale, Naranjo's algorithm), preventability (Modified Shumock and Thornton scale), severity (Modified Hartwig and Siegel scale), and predictors.
Main Results:
- The incidence of ADRs was 4.99% among 1082 enrolled pediatric patients.
- Gastrointestinal disorders were the most common ADRs, primarily associated with amoxicillin/clavulanate and ceftriaxone.
- Infants, males, and patients receiving ≥4 medications showed a significant association with ADR occurrence.
Conclusions:
- Infants, males, and children on multiple medications (≥4) are at higher risk for ADRs.
- Continuous monitoring and vigilance are essential for managing drug safety in pediatric patients, particularly vulnerable groups.
More Related Videos
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
369
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
369
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
458
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
458
01:26Pharmaceutical Poisoning: Potential Scenarios
75
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
75
01:29Drug Dosing: Infants and Children
726
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
726
01:24Drug Toxicity: Risk factors
148
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
148
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
693
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
693